Chemistry:BzODZ-EPyr
From HandWiki
Short description: Chemical compound
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C23H24N4O |
| Molar mass | 372.472 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
BzODZ-EPyr is an indole based synthetic cannabinoid that has been sold as a designer drug in Russia.[1]
It acts as a CB1 receptor agonist with a pKB value of 7.2 and demonstrates that replacing the ketone in 3-carbonylindoles with an oxadiazole spacer does not generally lead to activity loss.[2][3]
See also
References
- ↑ "Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances". Forensic Science International 259: 95–100. February 2016. doi:10.1016/j.forsciint.2015.12.019. PMID 26771874.
- ↑ "Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor". European Journal of Medicinal Chemistry 43 (3): 513–39. March 2008. doi:10.1016/j.ejmech.2007.04.007. PMID 17582659.
- ↑ Moloney PG, Robertson AD, "3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives", US patent 6930118, issued 2005, assigned to Amrad Operations Pty. Ltd.
 |  |
